Ezetimibe.....question?

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

HelloGoodbye

Full Member
15+ Year Member
Joined
May 26, 2007
Messages
128
Reaction score
0
I am just curious why bile acid resins (ex. cholestyramine) increase risk for gallstones, but cholesterol abosorption blockers (ex. ezetimibe) do not?

Is there any pharm people that really understand this?
 
I am just curious why bile acid resins (ex. cholestyramine) increase risk for gallstones, but cholesterol abosorption blockers (ex. ezetimibe) do not?

Is there any pharm people that really understand this?

Gallstone formation has to do with the relative concentrations of each ingredient in bile. Bile acid binding resins waste bile acids, leading to an increased concentration of cholesterol in bile relative to the other components == promotes gallstone formation.

The reason they lower cholesterol is because they promote the liver taking up cholesterol to produce more bile acids.

Cholesterol blockers simply decrease intestinal absorption of cholesterol, which decreases blood cholesterol levels.
 
Top